Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.15 - $3.05 $2.14 Million - $43.6 Million
14,285,714 New
14,285,714 $14.6 Million
Q2 2022

Aug 12, 2022

SELL
$2.66 - $5.81 $14.8 Million - $32.4 Million
-5,574,059 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$7.94 - $10.14 $44.3 Million - $56.5 Million
5,574,059 New
5,574,059 $46.1 Million

Others Institutions Holding LMDX

About LumiraDx Ltd


  • Ticker LMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 170,688,000
  • Market Cap $1.71M
  • Description
  • LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The compa...
More about LMDX
Track This Portfolio

Track Bill & Melinda Gates Foundation Portfolio

Follow Bill & Melinda Gates Foundation and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bill & Melinda Gates Foundation, based on Form 13F filings with the SEC.

News

Stay updated on Bill & Melinda Gates Foundation with notifications on news.